Bloomnberg Interview: Two-way connections with China’s financial markets are the real opportunity
Home ChinaAMC Hong Kong: Two-way connections with China’s financial markets are the real opportunity Read More Read more 2022-02-09 ChinaAMC (HK) – 2022 Market Outlook 2021-11-11 Recent highlight: Negotiations on the Catalog of Medicines covered by National Medical Insurance Read more
Market Insights – January 2022
Home .s0 { fill: #000000 } Download PDF Read more <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer adipie <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer adipie piscing […]
ChinaAMC(HK) received six awards in the 2021 Benchmark Fund of the Year Awards
Why choose MSCI China A 50 Connect ETF? (Chinese only)
Market Insights – December 2021
Home .s0 { fill: #000000 } Download PDF Read more <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer adipie <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer adipie piscing […]
Market Insights – November 2021
Home .s0 { fill: #000000 } Download PDF Read more <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer adipie <!– –> 2022-01-10 Lorem ipsum dolor sit amet consec tetuer adipiscing elit eneamodo uer adipie piscing […]
Recent highlight: Negotiations on the Catalog of Medicines covered by National Medical Insurance
Home Important Information Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in the ChinaAMC Hang Seng Hong Kong Biotech Index ETF (the “Fund”), investor should refer to the Fund’s prospectus for details, including the risk factors. You should not make investment decision based on the […]
ChinaAMC(HK) receives “The Greater Bay Area – Best Cross-Boundary Wealth Management Award”
Read More Read more 2021-11-08 ChinaAMC(HK) receives “The Greater Bay Area – Best Cross-Boundary Wealth Management Award” Read more 2021-12-09 ChinaAMC(HK) Proudly Introduces ChinaAMC MSCI China A 50 Connect ETF to the Market 2022-01-19 3197/83197-Announcement and Notice of Termination, Voluntary Deauthorisation and Delisting 2021-12-09 ChinaAMC (HK) Proudly Introduces ChinaAMC MSCI China A 50 Connect […]
【Upcoming Events】HKEX Biotech Summit 2021
Read More Read more 2022-01-19 3197/83197-Announcement and Notice of Termination, Voluntary Deauthorisation and Delisting 2021-12-09 ChinaAMC (HK) Proudly Introduces ChinaAMC MSCI China A 50 Connect ETF (Ticker: 2839) to the Market 2021-11-08 ChinaAMC(HK) receives “The Greater Bay Area – Best Cross-Boundary Wealth Management Award” Read more 2021-08-30 【Upcoming Events】HKEX Biotech Summit 2021 […]
ChinaAMC(HK) Appoints Clarence Chan as Head of ETFs
Read More Read more <!– –> 2021-08-30 【Upcoming Events】HKEX Biotech Summit 2021 Read more <!– –> 2021-11-08 ChinaAMC(HK) receives “The Greater Bay Area – Best Cross-Boundary Wealth Management Award” Read more <!– –> 2021-12-09 ChinaAMC(HK) Proudly Introduces ChinaAMC MSCI China A 50 Connect ETF to the Market <!– –> 2022-01-19 3197/83197-Announcement and Notice […]
